Video Experimental Relacionado
Updated: Sep 9, 2025
09:32
Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
12.5K
El noveno simposio científico anual de Lafora: una comunidad de epilepsia rara progresa hacia la preparación clínica
Meredith I Williams1, Katherine J Donohue2, Pascual Sanz3
1Chelsea's Hope Lafora Children Research Fund, 976 Maywick Dr. Lexington, KY 40504, USA; Department of Cellular and Molecular Biology, Baylor College of Medicine, 1 Baylor Plz, Houston, TX 77030 USA.
Epilepsy & behavior : E&B
|August 28, 2025
Resumen
La enfermedad de Lafora, una epilepsia fatal, está marcada por agregados anormales de glucógeno. Los investigadores se reunieron para avanzar en el desarrollo terapéutico y el descubrimiento de biomarcadores para los próximos ensayos clínicos.
Área de la Ciencia:
- La neurociencia
- La genética
- Trastornos del metabolismo
Sus antecedentes:
- La enfermedad de Lafora (LD) es una epilepsia mioclónica progresiva y un trastorno de almacenamiento de glucógeno con inicio en la infancia.
- La LD es el resultado de mutaciones recesivas en los genes EPM2A o EPM2B.
- Los agregados de glucógeno citoplasmáticos aberrantes, conocidos como cuerpos de Lafora (LB), son el sello patológico y impulsan la progresión de la enfermedad.
Objetivo del estudio:
- Fomentar las colaboraciones internacionales para el desarrollo terapéutico de la enfermedad de Lafora.
- Identificar biomarcadores fiables para el seguimiento y la progresión de la enfermedad.
- Para preparar a la comunidad de pacientes de Lafora para los próximos ensayos clínicos.
Principales métodos:
- El 9o Simposio Anual de Ciencias Lafora convocó a investigadores, médicos, aprendices y defensores de los pacientes.
- Las discusiones se centraron en estrategias de colaboración para el desarrollo de fármacos y la investigación de biomarcadores.
- Las presentaciones y talleres abordaron la preparación de la comunidad de pacientes para los ensayos clínicos.
Principales resultados:
- El simposio reunió con éxito a más de 70 personas en persona y 80 asistentes virtuales.
- Los temas clave incluyeron el avance de las colaboraciones internacionales de investigación y la identificación de biomarcadores.
- Se discutieron estrategias para involucrar a la comunidad de Lafora en la preparación para ensayos clínicos.
Conclusiones:
- El 9o Simposio Anual de Ciencias Lafora destacó la importancia de la colaboración mundial en la lucha contra la enfermedad de Lafora.
- El progreso en el desarrollo terapéutico y el descubrimiento de biomarcadores se está acelerando.
- Un mayor compromiso de la comunidad es crucial para el éxito de los ensayos clínicos futuros.
Palabras clave:
Demencia infantilGlicógenoEnfermedad del almacenamiento de glucógenoEnfermedad de LaforaEpilepsia mioclónica progresivaMás Videos Relacionados
05:54Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
17.4K
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
2.8K
Videos de Conceptos Relacionados
01:24Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:28Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
01:16Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
01:13Seizures: Classification
584
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
584
01:30Electroconvulsive Therapy
182
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
182